Edwards Lifesciences

Edwards Lifesciences is a global leader in structural heart innovation, focusing on medical advancements for structural heart disease, critical care, surgical monitoring, and cardiovascular therapies. Headquartered in Irvine, California, the company operates in multiple regions, including North America, Europe, Japan, Latin America, and Asia, employing over 13,000 people worldwide. Founded in 1958, Edwards Lifesciences pioneered heart valve technology with the development of the first commercially available artificial heart valve. The company designs and markets a wide range of products for late-stage cardiovascular disease. Its core offerings include tissue replacement heart valves, mechanical valves, and transcatheter valves, as well as hemodynamic monitoring tools and surgical products. Edwards Lifesciences emphasizes innovation through partnerships with clinicians and researchers, continually advancing solutions for patients with cardiovascular conditions. The company is dedicated to improving the quality of life for those affected by heart disease, positioning itself as a trusted partner in cardiac surgery and critical care.